Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2546381018 | Incretin mimetic agent (substance) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2548670015 | Incretin mimetic agent | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3720002019 | Glucagon-like peptide 1 receptor agonist | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3720003012 | Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3722683016 | Incretin mimetic | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3761503014 | GLP-1 receptor agonist | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Glucagon-like peptide 1 receptor agonist | Is a | Antidiabetic agent | false | Inferred relationship | Some | ||
| Glucagon-like peptide 1 receptor agonist | Is a | Incretin (substance) | false | Inferred relationship | Some | ||
| Glucagon-like peptide 1 receptor agonist | Has disposition (attribute) | Hormone (disposition) | false | Inferred relationship | Some | ||
| Glucagon-like peptide 1 receptor agonist | Has disposition (attribute) | Glucagon-like peptide 1 receptor agonist | true | Inferred relationship | Some | ||
| Glucagon-like peptide 1 receptor agonist | Is a | Substance categorized by disposition | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Exenatide (substance) | Is a | True | Glucagon-like peptide 1 receptor agonist | Inferred relationship | Some | |
| Glucagon-like peptide 1 receptor agonist-containing product | Has active ingredient | True | Glucagon-like peptide 1 receptor agonist | Inferred relationship | Some | 1 |
| Liraglutide (substance) | Is a | True | Glucagon-like peptide 1 receptor agonist | Inferred relationship | Some | |
| Incretin mimetic therapy | Direct substance | True | Glucagon-like peptide 1 receptor agonist | Inferred relationship | Some | 2 |
| Albiglutide (substance) | Is a | True | Glucagon-like peptide 1 receptor agonist | Inferred relationship | Some | |
| Lixisenatide | Is a | True | Glucagon-like peptide 1 receptor agonist | Inferred relationship | Some | |
| Dulaglutide (substance) | Is a | True | Glucagon-like peptide 1 receptor agonist | Inferred relationship | Some | |
| Semaglutide (substance) | Is a | True | Glucagon-like peptide 1 receptor agonist | Inferred relationship | Some | |
| Tirzepatide | Is a | True | Glucagon-like peptide 1 receptor agonist | Inferred relationship | Some |
This concept is not in any reference sets
FHIR